Carnosine And Anti-Ageing
Quick Read Carnosine is a small molecule your muscles naturally produce that declines with age. Research suggests it fights three
Subscribe to the distribution list, to get regular updates on supplement research for health,
🧠 NeuroBright Our evidence-based brain supplement formulated from 1.7M research papers
What if the fatigue you’ve been writing off as “just getting older” is partly a chemistry problem — one that researchers are actively working to solve? Not with a wonder drug, not with some exotic plant extract, but with a molecule your cells have been making and using since the very beginning of life. NAD+ — nicotinamide adenine dinucleotide — sits at the heart of nearly every energy-producing reaction in your body. And here’s the uncomfortable truth: by the time you’re in your 40s and 50s, your NAD+ levels may already be significantly lower than they were in your 20s. The research on what that means — and what you can do about it — is moving fast. The Vitacuity database returned 15 papers on this topic, and what they reveal is genuinely fascinating. Not settled science. Not a miracle cure. But a compelling, evidence-based story about one of the most important molecules in ageing biology.
Think of NAD+ as the energy relay baton inside your cells. Every time your body converts food into usable energy — whether from carbohydrates, fats or proteins — NAD+ is the molecule doing much of the carrying work. It shuttles electrons through a process called oxidative phosphorylation in your mitochondria (the power stations of your cells), ultimately producing ATP, the currency your body actually spends on every biological function you can name [13].
But NAD+ does far more than just power your cells. It acts as a critical signalling molecule, activating a family of proteins called sirtuins — sometimes called “longevity proteins” — that regulate inflammation, DNA repair, gene expression and stress responses [10]. It also feeds into PARP enzymes (poly-ADP-ribose polymerases), which are your cells’ first responders for DNA damage repair [15]. And it plays roles in calcium signalling and immune regulation [8].
Here’s where ageing enters the picture. NAD+ levels decline measurably as we age — a finding that appears consistently across the research [1][2][5]. This isn’t a minor dip. Some researchers describe it as one of the central metabolic features of ageing itself. As NAD+ falls, mitochondria function less efficiently, DNA repair slows, sirtuins become less active, and the cascade of biological changes we associate with ageing accelerates [13][2].
Your body makes NAD+ through several routes: from scratch using the amino acid tryptophan (the “de novo” pathway), and through salvage pathways that recycle precursor molecules from your diet — primarily forms of vitamin B3, including nicotinic acid (NA), nicotinamide (NAM), nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) [8][13]. The research focus has largely been on using these precursors as supplements to top NAD+ levels back up.
The decline of NAD+ with age isn’t a hypothesis — it’s one of the most replicated observations in ageing biology. Multiple review papers in the Vitacuity database confirm this as a consistent finding across human and animal studies [1][2][12].
A comprehensive 2021 review published in *Nature Reviews Molecular Cell Biology* [2] describes NAD+ decline as a hallmark of ageing that directly affects energy metabolism and mitochondrial function. Crucially, this isn’t just a passive symptom of ageing — the decline in NAD+ appears to actively drive some of the changes we associate with getting older, including reduced mitochondrial efficiency and impaired cellular repair mechanisms.
A 2020 systematic review in *Experimental Gerontology* [8] is particularly illuminating. Reviewing 147 studies (113 preclinical and 34 clinical), it found that NAD+ precursors — including NAM, NR and NMN — showed favourable outcomes across a range of age-related conditions linked to oxidative stress, inflammation and mitochondrial dysfunction. The authors noted the compounds had a “limited acute toxicity profile,” which is important context for anyone weighing up whether to supplement.
Evidence grade: Strong for the existence and significance of age-related NAD+ decline. Strong for the basic biology. More promising-to-early-stage for what supplementation achieves in humans specifically.
The most practically important question is: if you take an NR or NMN supplement, does it actually raise your NAD+ levels? The answer, based on current evidence, is yes — at least in the short term.
A 2024 review published in the *American Journal of Physiology — Endocrinology and Metabolism* [3] assessed randomised controlled trials specifically looking at NAD+ supplementation in humans. It confirmed that both NR and NMN supplementation reliably increase blood NAD+ levels in human participants. The precursors differ in how they enter cells and how efficiently they raise NAD+ in different tissues, and the authors note that not all studies show the same magnitude of effect.
A 2024 paper [4] specifically looking at nicotinic acid and its derivatives found that supplementation up-regulates cellular NAD+ levels — though how this translates to functional benefits varies by form and dosage.
What’s less clear is whether raising NAD+ in the blood necessarily means all your tissues — including the brain, muscle and heart — are getting the benefit. This is a genuine and important gap in the current evidence, which we’ll come back to in the “What We Don’t Know Yet” section.
Evidence grade: Promising to strong that NAD+ precursors raise blood NAD+ levels in humans. Promising (but not yet strong) that this translates to measurable functional benefits in healthy middle-aged adults.
One of the more exciting recent developments in NAD+ research involves its role in DNA repair — specifically its relationship with PARP enzymes. When your DNA gets damaged (from UV light, pollution, normal metabolic processes, or just the wear and tear of living), PARP enzymes are the first responders. They consume NAD+ in the process of signalling and coordinating repairs [15].
A 2026 paper published in *Aging Cell* [15] highlights a concerning feedback loop: as NAD+ declines with age, DNA repair becomes less efficient. But when PARP enzymes are chronically overactivated — as happens in various DNA repair disorders and possibly in normal ageing — they can deplete NAD+ further, creating a downward spiral. The paper reports that in model systems mimicking premature ageing diseases, NAD+ supplementation improved DNA repair capacity and mitochondrial function.
A 2024 paper [5] reinforces this connection, noting that sirtuins — the longevity proteins that depend on NAD+ — are “defensive deacylases” that also play protective roles in DNA maintenance, and that their activity is compromised when NAD+ levels fall.
Evidence grade: Promising — compelling mechanistic evidence and promising signals from model systems and early human studies. Full confirmation in large human trials is still pending.
Sirtuins deserve their own section because they represent one of the most important downstream effects of NAD+ status. There are seven sirtuins (SIRT1–SIRT7) in human cells, and they regulate an extraordinary range of processes: inflammation, gene expression, fat metabolism, circadian rhythm, cellular stress responses and — critically — healthy ageing [13][10].
Sirtuins cannot function without NAD+. They are, quite literally, switched off when NAD+ is depleted. A 2016 review in *Chinese Medicine* [13] explains this clearly: “Raising cellular NAD+ content… leads to sirtuins activation. Sirtuins modulate distinct metabolic, energetic and stress response pathways, and through their activation, NAD+ directly links the cellular redox state with signaling and transcriptional events.”
A 2018 review in *Cell Metabolism* [10] describes NAD+ as having emerged as a “signalling molecule” — beyond its classical role as a hydrogen carrier — that, by modulating NAD+-dependent enzymes including sirtuins, influences longevity pathways in animal models. The same review acknowledges that translating these findings to humans at meaningful effect sizes is still work in progress.
Evidence grade: Strong for the NAD+-sirtuin biological connection. Promising for the practical implications of boosting NAD+ to activate sirtuins in ageing humans.
Ageing isn’t just about individual cells running out of energy — it’s about the accumulation of damaged, dysfunctional cells that should have been cleared away but weren’t. This is called cellular senescence, and it’s one of the major drivers of age-related disease. A 2024 paper in the *Journal of Cellular Biochemistry* [9] examined the relationship between NAD+, mitochondrial function and T-cell senescence in mice. It found that NAD+ decline is associated with mitochondrial dysfunction in immune cells, which in turn drives the inflammatory “zombie cell” state of senescence.
The implication is significant: maintaining NAD+ levels may not just keep your mitochondria running efficiently — it may help prevent the accumulation of senescent cells that drive chronic inflammation (sometimes called “inflammageing”) in later life.
A 2023 review in *Antioxidants & Redox Signalling* [6] also notes the importance of NAD+ metabolism in maintaining healthy mitochondrial function, and highlights NMN and NR as the most studied supplementation forms for this purpose.
It’s worth noting that this research is largely preclinical — much of it done in mice. The biological logic is compelling, but we need more human data to confirm these effects translate meaningfully.
Evidence grade: Early stage to promising — strong animal and mechanistic data, emerging human signals. Not yet confirmed in large human trials.
Not all NAD+ supplements are created equal, and the research makes this clear. The main precursor forms studied are: nicotinamide (NAM), nicotinic acid (NA), nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). They differ in their metabolic pathways into the cell, their bioavailability, and their side effect profiles [12][6].
A 2023 review in *Drugs & Aging* [12] provides a useful breakdown: “While it is anticipated that NAD+ precursors can play beneficial protective roles in several conditions, they vary in their ability to promote NAD+ anabolism with differing adverse effects.” Nicotinic acid (classic niacin) is cheap and effective but causes flushing in many people. Nicotinamide doesn’t cause flushing but may have some inhibitory effects on sirtuins at high doses. NR and NMN appear to have better tolerability profiles and have been the main focus of modern clinical research.
A 2021 paper in the *Journal of Biological Chemistry* [14] adds an interesting layer of complexity: when cells are exposed to external NAD+, intracellular levels initially rise — but then reset back towards baseline. This “iNAD+ resetting” phenomenon suggests cells actively regulate their NAD+ homeostasis, which may partly explain why some studies show smaller or more transient effects than expected. The same paper found that oxygen and ATP consumption increased with NAD+ exposure, suggesting metabolic activation even when intracellular levels returned to normal.
Evidence grade: Promising — meaningful human trial data exists, but optimal dosing, form and population are still being refined.
This is where we have to be genuinely honest — and there’s quite a lot to say here.
Does raising blood NAD+ actually fix things in humans? The gap between “this molecule is important” and “supplementing it produces measurable health benefits in middle-aged adults” is larger than the popular press would have you believe. Most of the dramatic results — extended lifespan, reversed mitochondrial decline, improved muscle function — come from animal studies. A 2020 systematic review [8] that looked at 147 studies found the human clinical trial evidence is still “nascent.” A 2024 review [3] of human RCTs confirmed that supplements raise blood NAD+ but was more cautious about functional outcomes.
Which tissues actually benefit? Raising NAD+ in the blood doesn’t guarantee it reaches the brain, heart or skeletal muscle in meaningful amounts. Tissue-specific effects are not well characterised in humans yet.
Who benefits most? A 2026 paper [15] raises a genuinely important point: “Some studies show no observable advantages” and the discrepancy may come down to who is being studied. People with pre-existing NAD+ depletion — whether from DNA repair disorders, metabolic stress, or simple ageing — may benefit far more than those with normal levels. The concept of “baseline NAD+ status” as a predictor of supplement response is underexplored.
Long-term safety? The short-term safety profile looks reassuring [8], but the 2020 systematic review specifically flags concerns worth knowing about: the potential accumulation of toxic metabolites from chronic supplementation, theoretical questions about tumorigenesis (since NAD+ also fuels cancer cell metabolism), and the promotion of cellular senescence in some contexts. These are not reasons to panic — but they are reasons why long-term, large-scale human trials matter and are currently lacking.
The resetting problem. The 2021 *Journal of Biological Chemistry* paper [14] found that cells may actively reset their NAD+ levels after supplementation. If this happens in vivo in humans, it raises questions about how to supplement effectively over time.
Does it actually make you feel better? Subjective energy, cognitive function and wellbeing haven’t been consistently measured or improved in human trials. The mechanistic story is compelling. The clinical story is still catching up.
Here’s how a well-informed, practically minded person should think about NAD+ supplementation right now.
The biology is genuinely compelling — NAD+ decline with age is real and well-documented, the downstream effects on mitochondria, DNA repair and cellular health are mechanistically important, and the supplements are, in the short term, safe and do raise NAD+ levels. That’s a meaningful starting point.
The human evidence for functional benefits — more energy, better cognitive function, measurable healthspan improvements — is promising but not yet strong. This is not junk science and it’s not a miracle cure. It sits in that frustrating but real middle ground: “we have good reasons to think this matters, and early human signals are encouraging, but we’re waiting for larger, longer trials.”
So what would a sensible, informed person actually do?
If you’re in your 40s, 50s or 60s and thinking about NAD+ supplementation: The risk-benefit calculation looks reasonable. NAD+ precursors — particularly NR and NMN — have a good short-term safety profile, they demonstrably raise NAD+ levels, and the mechanistic case for why this matters is solid. If cost is a factor, consider that nicotinamide (plain B3) is the cheapest precursor, though the more bioavailable NR and NMN forms are what most clinical research has used. Typical doses in human studies have ranged from 250mg to 500mg daily of NR or NMN — this is what the research has been conducted at.
Don’t expect a dramatic transformation overnight. NAD+ supplementation is not a stimulant. If it works, it’s working at the cellular level over time — maintaining mitochondrial function, supporting DNA repair, keeping sirtuin activity from declining further. Think of it as maintenance, not medicine.
Be appropriately cautious if you have a history of cancer — the theoretical concern about NAD+ fuelling cancer cell metabolism is not proven in humans but is worth discussing with a clinician in that specific context.
Keep an eye on this space. This is one of the fastest-moving areas in ageing biology. The next three to five years of human trial data will tell us considerably more about who benefits most and at what doses.
The honest summary: the science gives you enough reason to be interested, and not enough reason to be either dismissed or oversold. NAD+ is real, its decline with age is real, and the precursor supplements are safe enough to be a reasonable choice — especially if you’re someone who takes their cellular health seriously.
[1] NAD+ supplementation and ageing (2021). DOI: 10.1016/j.coph.2021.08.006 | https://pubmed.ncbi.nlm.nih.gov/34507029/
[2] NAD+ metabolism and its roles in cellular processes during ageing (2021). DOI: 10.1038/s41580-020-00313-x | https://pubmed.ncbi.nlm.nih.gov/33353981/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963035/
[3] Review of NAD+ supplementation RCTs in humans (2024). DOI: 10.1152/ajpendo.00242.2023 | https://pubmed.ncbi.nlm.nih.gov/37971292/
[4] Supplementation of Nicotinic Acid and Its Derivatives Up-Regulates Cellular NAD+ (2024). https://pubmed.ncbi.nlm.nih.gov/38541737/
[5] NAD+, sirtuins and DNA repair in ageing (2024). DOI: 10.1101/2024.06.21.599604 | https://pubmed.ncbi.nlm.nih.gov/38979132/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11230277/
[6] NAD+ metabolism and supplementation therapy (2023). DOI: 10.1089/ars.2023.0354 | https://pubmed.ncbi.nlm.nih.gov/37335049/
[7] NAD+ in cellular function and ageing (2018). https://pubmed.ncbi.nlm.nih.gov/29744033/
[8] Systematic review of NAD+ precursors for age-related disorders (2020). DOI: 10.1016/j.exger.2020.110831 | https://pubmed.ncbi.nlm.nih.gov/31917996/
[9] NAD+, mitochondrial homeostasis and T-cell senescence (2024). DOI: 10.1002/jcb.30522 | https://pubmed.ncbi.nlm.nih.gov/38224175/
[10] Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence (2018). https://pubmed.ncbi.nlm.nih.gov/29514064/
[11] Emerging potential benefits of modulating NAD+ in cardiovascular health (2018). https://pubmed.ncbi.nlm.nih.gov/29351465/
[12] NAD+ precursors and age-related disease: clinical utility review (2023). DOI: 10.1007/s40266-022-00989-0 | https://pubmed.ncbi.nlm.nih.gov/36510042/
[13] NAD+ metabolism and role in energy homeostasis (2016). DOI: 10.1186/s40169-016-0104-7 | https://pubmed.ncbi.nlm.nih.gov/27465020/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963347/
[14] Intracellular NAD+ resetting and bioenergetics (2021). DOI: 10.1016/j.jbc.2021.100855 | https://pubmed.ncbi.nlm.nih.gov/34097876/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233143/
[15] NAD+ supplementation, DNA repair and premature ageing diseases (2026). DOI: 10.1111/acel.70319 | https://pubmed.ncbi.nlm.nih.gov/41436848/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12727671/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Carnosine is a small molecule your muscles naturally produce that declines with age. Research suggests it fights three
Quick Read CoQ10 is a molecule found in your cells’ power stations (mitochondria) that helps convert food into energy your
